HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,987 | +11.5% | 1,963 | +5.3% | 0.01% | +14.3% |
| Q2 2023 | $67,271 | +13.1% | 1,865 | +19.8% | 0.01% | 0.0% |
| Q1 2023 | $59,462 | -45.2% | 1,557 | -18.3% | 0.01% | -46.2% |
| Q4 2022 | $108,451 | +23.2% | 1,906 | -14.8% | 0.01% | -13.3% |
| Q3 2022 | $88,000 | -8.3% | 2,237 | +2.1% | 0.02% | -6.2% |
| Q2 2022 | $96,000 | +10.3% | 2,191 | +0.6% | 0.02% | +23.1% |
| Q1 2022 | $87,000 | -34.1% | 2,178 | -33.8% | 0.01% | -35.0% |
| Q4 2021 | $132,000 | +6500.0% | 3,288 | +7546.5% | 0.02% | +1900.0% |
| Q3 2021 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 43 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 43 | -23.2% | 0.00% | – |
| Q1 2020 | $1,000 | -92.9% | 56 | -94.4% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |